These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 19138260

  • 1. Intraoperative autologous blood recovery in prostate cancer surgery: in vivo validation using a tumour marker.
    Poli M, Camargo A, Villa L, Moura R, Colella R, Deheinzelin D.
    Vox Sang; 2008 Nov; 95(4):308-12. PubMed ID: 19138260
    [Abstract] [Full Text] [Related]

  • 2. Molecular evidence of tumour cell removal from salvaged blood after irradiation and leucocyte depletion.
    Poli MC, Villa LL, Colella R, Deheinzelin D.
    Transfus Med; 2004 Apr; 14(2):151-5. PubMed ID: 15113379
    [Abstract] [Full Text] [Related]

  • 3. Hypermethylation of the CpG islands in the promoter region of the GSTP1 gene in prostate cancer: a useful diagnostic and prognostic marker?
    Bernardini S, Miano R, Iori R, Finazzi-Agrò E, Palmieri G, Ballerini S, Angeloni C, Orlandi A, Bellincampi L, Cortese C, Federici G.
    Clin Chim Acta; 2004 Dec; 350(1-2):181-8. PubMed ID: 15530476
    [Abstract] [Full Text] [Related]

  • 4. Hypermethylation of the CpG islands in the promoter region flanking GSTP1 gene is a potential plasma DNA biomarker for detecting prostate carcinoma.
    Chuang CK, Chu DC, Tzou RD, Liou SI, Chia JH, Sun CF.
    Cancer Detect Prev; 2007 Dec; 31(1):59-63. PubMed ID: 17291695
    [Abstract] [Full Text] [Related]

  • 5. Association of circulating tumor cells with tumor-related methylated DNA in patients with hormone-refractory prostate cancer.
    Okegawa T, Nutahara K, Higashihara E.
    Int J Urol; 2010 May; 17(5):466-75. PubMed ID: 20337729
    [Abstract] [Full Text] [Related]

  • 6. Detection of GSTP1 methylation in prostatic secretions using combinatorial MSP analysis.
    Gonzalgo ML, Nakayama M, Lee SM, De Marzo AM, Nelson WG.
    Urology; 2004 Feb; 63(2):414-8. PubMed ID: 14972513
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.
    Zon G, Barker MA, Kaur P, Groshen S, Jones LW, Imam SA, Boyd VL.
    Anal Biochem; 2009 Sep 15; 392(2):117-25. PubMed ID: 19505431
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prospective diagnostic efficiency of biopsy washing DNA GSTP1 island hypermethylation for detection of adenocarcinoma of the prostate.
    Eilers T, Machtens S, Tezval H, Blaue C, Lichtinghagen R, Hagemann J, Jonas U, Serth J.
    Prostate; 2007 May 15; 67(7):757-63. PubMed ID: 17373715
    [Abstract] [Full Text] [Related]

  • 14. Methylation analysis of BRCA1, RASSF1, GSTP1 and EPHB2 promoters in prostate biopsies according to different degrees of malignancy.
    Rabiau N, Thiam MO, Satih S, Guy L, Kemeny JL, Boiteux JP, Fontana L, Bignon YJ, Bernard-Gallon D.
    In Vivo; 2009 May 15; 23(3):387-91. PubMed ID: 19454503
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Genetic and epigenetic SLC18A2 silencing in prostate cancer is an independent adverse predictor of biochemical recurrence after radical prostatectomy.
    Sørensen KD, Wild PJ, Mortezavi A, Adolf K, Tørring N, Heebøll S, Ulhøi BP, Ottosen P, Sulser T, Hermanns T, Moch H, Borre M, Ørntoft TF, Dyrskjøt L.
    Clin Cancer Res; 2009 Feb 15; 15(4):1400-10. PubMed ID: 19228741
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Microsatellite analysis of allelic imbalance in tumour and blood from patients with prostate cancer.
    Schwarzenbach H, Chun FK, Müller I, Seidel C, Urban K, Erbersdobler A, Huland H, Pantel K, Friedrich MG.
    BJU Int; 2008 Jul 15; 102(2):253-8. PubMed ID: 18336598
    [Abstract] [Full Text] [Related]

  • 19. Use of a leucocyte filter to remove tumour cells from intra-operative cell salvage blood.
    Catling S, Williams S, Freites O, Rees M, Davies C, Hopkins L.
    Anaesthesia; 2008 Dec 15; 63(12):1332-8. PubMed ID: 19032302
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.